Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study

Standard

Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study. / Woelber, Linn; Griebel, Lis-Femke; Eulenburg, Christine; Sehouli, Jalid; Jueckstock, Julia; Hilpert, Felix; de Gregorio, Nikolaus; Hasenburg, Annette; Ignatov, Atanas; Hillemanns, Peter; Fuerst, Sophie; Strauss, Hans-Georg; Baumann, Klaus H; Thiel, Falk C; Mustea, Alexander; Meier, Werner; Harter, Philipp; Wimberger, Pauline; Hanker, Lars Christian; Schmalfeldt, Barbara; Canzler, Ulrich; Fehm, Tanja; Luyten, Alexander; Hellriegel, Martin; Kosse, Jens; Heiss, Christoph; Hantschmann, Peer; Mallmann, Peter; Tanner, Berno; Pfisterer, Jacobus; Richter, Barbara; Neuser, Petra; Mahner, Sven.

in: EUR J CANCER, Jahrgang 69, 12.2016, S. 180-188.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Woelber, L, Griebel, L-F, Eulenburg, C, Sehouli, J, Jueckstock, J, Hilpert, F, de Gregorio, N, Hasenburg, A, Ignatov, A, Hillemanns, P, Fuerst, S, Strauss, H-G, Baumann, KH, Thiel, FC, Mustea, A, Meier, W, Harter, P, Wimberger, P, Hanker, LC, Schmalfeldt, B, Canzler, U, Fehm, T, Luyten, A, Hellriegel, M, Kosse, J, Heiss, C, Hantschmann, P, Mallmann, P, Tanner, B, Pfisterer, J, Richter, B, Neuser, P & Mahner, S 2016, 'Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study', EUR J CANCER, Jg. 69, S. 180-188. https://doi.org/10.1016/j.ejca.2016.09.038

APA

Woelber, L., Griebel, L-F., Eulenburg, C., Sehouli, J., Jueckstock, J., Hilpert, F., de Gregorio, N., Hasenburg, A., Ignatov, A., Hillemanns, P., Fuerst, S., Strauss, H-G., Baumann, K. H., Thiel, F. C., Mustea, A., Meier, W., Harter, P., Wimberger, P., Hanker, L. C., ... Mahner, S. (2016). Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study. EUR J CANCER, 69, 180-188. https://doi.org/10.1016/j.ejca.2016.09.038

Vancouver

Bibtex

@article{2374d1914ffa48ac9b7bc62bc35c3195,
title = "Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gyn{\"a}kologische Onkologie CaRE-1 multicenter study",
abstract = "AIM OF THE STUDY: A tumour-free pathological resection margin of ≥8 mm is considered state-of-the-art. Available evidence is based on heterogeneous cohorts. This study was designed to clarify the relevance of the resection margin for loco-regional control in vulvar cancer.METHODS: AGO-CaRE-1 is a large retrospective study. Patients (n = 1618) with vulvar cancer ≥ FIGO stage IB treated at 29 German gynecologic-cancer-centres 1998-2008 were included. This subgroup analysis focuses on solely surgically treated node-negative patients with complete tumour resection (n = 289).RESULTS: Of the 289 analysed patients, 141 (48.8%) had pT1b, 140 (48.4%) pT2 and 8 (2.8%) pT3 tumours. One hundred twenty-five (43.3%) underwent complete vulvectomy, 127 (43.9%) partial vulvectomy and 37 (12.8%) radical local excision. The median minimal resection margin was 5 mm (1 mm-33 mm); all patients received groin staging, in 86.5% with full dissection. Median follow-up was 35.1 months. 46 (15.9%) patients developed recurrence, thereof 34 (11.8%) at the vulva, after a median of 18.3 months. Vulvar recurrence rates were 12.6% in patients with a margin <8 mm and 10.2% in patients with a margin ≥8 mm. When analysed as a continuous variable, the margin distance had no statistically significant impact on local recurrence (HR per mm increase: 0.930, 95% CI: 0.849-1.020; p = 0.125). Multivariate analyses did also not reveal a significant association between the margin and local recurrence neither when analysed as continuous variable nor categorically based on the 8 mm cutoff. Results were consistent when looking at disease-free-survival and time-to-recurrence at any site (HR per mm increase: 0.949, 95% CI: 0.864-1.041; p = 0.267).CONCLUSIONS: The need for a minimal margin of 8 mm could not be confirmed in the large and homogeneous node-negative cohort of the AGO-CaRE database.",
author = "Linn Woelber and Lis-Femke Griebel and Christine Eulenburg and Jalid Sehouli and Julia Jueckstock and Felix Hilpert and {de Gregorio}, Nikolaus and Annette Hasenburg and Atanas Ignatov and Peter Hillemanns and Sophie Fuerst and Hans-Georg Strauss and Baumann, {Klaus H} and Thiel, {Falk C} and Alexander Mustea and Werner Meier and Philipp Harter and Pauline Wimberger and Hanker, {Lars Christian} and Barbara Schmalfeldt and Ulrich Canzler and Tanja Fehm and Alexander Luyten and Martin Hellriegel and Jens Kosse and Christoph Heiss and Peer Hantschmann and Peter Mallmann and Berno Tanner and Jacobus Pfisterer and Barbara Richter and Petra Neuser and Sven Mahner",
note = "Copyright {\^A}{\textcopyright} 2016 Elsevier Ltd. All rights reserved.",
year = "2016",
month = dec,
doi = "10.1016/j.ejca.2016.09.038",
language = "English",
volume = "69",
pages = "180--188",
journal = "EUR J CANCER",
issn = "0959-8049",
publisher = "Elsevier Limited",

}

RIS

TY - JOUR

T1 - Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study

AU - Woelber, Linn

AU - Griebel, Lis-Femke

AU - Eulenburg, Christine

AU - Sehouli, Jalid

AU - Jueckstock, Julia

AU - Hilpert, Felix

AU - de Gregorio, Nikolaus

AU - Hasenburg, Annette

AU - Ignatov, Atanas

AU - Hillemanns, Peter

AU - Fuerst, Sophie

AU - Strauss, Hans-Georg

AU - Baumann, Klaus H

AU - Thiel, Falk C

AU - Mustea, Alexander

AU - Meier, Werner

AU - Harter, Philipp

AU - Wimberger, Pauline

AU - Hanker, Lars Christian

AU - Schmalfeldt, Barbara

AU - Canzler, Ulrich

AU - Fehm, Tanja

AU - Luyten, Alexander

AU - Hellriegel, Martin

AU - Kosse, Jens

AU - Heiss, Christoph

AU - Hantschmann, Peer

AU - Mallmann, Peter

AU - Tanner, Berno

AU - Pfisterer, Jacobus

AU - Richter, Barbara

AU - Neuser, Petra

AU - Mahner, Sven

N1 - Copyright © 2016 Elsevier Ltd. All rights reserved.

PY - 2016/12

Y1 - 2016/12

N2 - AIM OF THE STUDY: A tumour-free pathological resection margin of ≥8 mm is considered state-of-the-art. Available evidence is based on heterogeneous cohorts. This study was designed to clarify the relevance of the resection margin for loco-regional control in vulvar cancer.METHODS: AGO-CaRE-1 is a large retrospective study. Patients (n = 1618) with vulvar cancer ≥ FIGO stage IB treated at 29 German gynecologic-cancer-centres 1998-2008 were included. This subgroup analysis focuses on solely surgically treated node-negative patients with complete tumour resection (n = 289).RESULTS: Of the 289 analysed patients, 141 (48.8%) had pT1b, 140 (48.4%) pT2 and 8 (2.8%) pT3 tumours. One hundred twenty-five (43.3%) underwent complete vulvectomy, 127 (43.9%) partial vulvectomy and 37 (12.8%) radical local excision. The median minimal resection margin was 5 mm (1 mm-33 mm); all patients received groin staging, in 86.5% with full dissection. Median follow-up was 35.1 months. 46 (15.9%) patients developed recurrence, thereof 34 (11.8%) at the vulva, after a median of 18.3 months. Vulvar recurrence rates were 12.6% in patients with a margin <8 mm and 10.2% in patients with a margin ≥8 mm. When analysed as a continuous variable, the margin distance had no statistically significant impact on local recurrence (HR per mm increase: 0.930, 95% CI: 0.849-1.020; p = 0.125). Multivariate analyses did also not reveal a significant association between the margin and local recurrence neither when analysed as continuous variable nor categorically based on the 8 mm cutoff. Results were consistent when looking at disease-free-survival and time-to-recurrence at any site (HR per mm increase: 0.949, 95% CI: 0.864-1.041; p = 0.267).CONCLUSIONS: The need for a minimal margin of 8 mm could not be confirmed in the large and homogeneous node-negative cohort of the AGO-CaRE database.

AB - AIM OF THE STUDY: A tumour-free pathological resection margin of ≥8 mm is considered state-of-the-art. Available evidence is based on heterogeneous cohorts. This study was designed to clarify the relevance of the resection margin for loco-regional control in vulvar cancer.METHODS: AGO-CaRE-1 is a large retrospective study. Patients (n = 1618) with vulvar cancer ≥ FIGO stage IB treated at 29 German gynecologic-cancer-centres 1998-2008 were included. This subgroup analysis focuses on solely surgically treated node-negative patients with complete tumour resection (n = 289).RESULTS: Of the 289 analysed patients, 141 (48.8%) had pT1b, 140 (48.4%) pT2 and 8 (2.8%) pT3 tumours. One hundred twenty-five (43.3%) underwent complete vulvectomy, 127 (43.9%) partial vulvectomy and 37 (12.8%) radical local excision. The median minimal resection margin was 5 mm (1 mm-33 mm); all patients received groin staging, in 86.5% with full dissection. Median follow-up was 35.1 months. 46 (15.9%) patients developed recurrence, thereof 34 (11.8%) at the vulva, after a median of 18.3 months. Vulvar recurrence rates were 12.6% in patients with a margin <8 mm and 10.2% in patients with a margin ≥8 mm. When analysed as a continuous variable, the margin distance had no statistically significant impact on local recurrence (HR per mm increase: 0.930, 95% CI: 0.849-1.020; p = 0.125). Multivariate analyses did also not reveal a significant association between the margin and local recurrence neither when analysed as continuous variable nor categorically based on the 8 mm cutoff. Results were consistent when looking at disease-free-survival and time-to-recurrence at any site (HR per mm increase: 0.949, 95% CI: 0.864-1.041; p = 0.267).CONCLUSIONS: The need for a minimal margin of 8 mm could not be confirmed in the large and homogeneous node-negative cohort of the AGO-CaRE database.

U2 - 10.1016/j.ejca.2016.09.038

DO - 10.1016/j.ejca.2016.09.038

M3 - SCORING: Journal article

C2 - 27837710

VL - 69

SP - 180

EP - 188

JO - EUR J CANCER

JF - EUR J CANCER

SN - 0959-8049

ER -